Celiac disease (CeD) is a common immune-mediated condition that occurs in genetically predisposed individuals. In this study, we examined the trajectory of tissue transglutaminase IgA (tTG-IgA) antibodies in a prospective longitudinal cohort of over 500 children at risk of developing CeD due to having a first-degree relative with CeD. We identified 34 subjects from our cohort and examined tTG-IgA titers at seroconversion and 6 months before tTG-IgA seroconversion. We found that all subjects had normal tTG-IgA 6 months before seroconversion. Thus, we conclude that tTG-IgA elevation in subjects with CeD is a sudden event and its trajectory cannot be used as a marker to predict seroconversion in this population.

Elevation of tTG-IgA Antibodies in a Prospective Cohort of Children at Risk of Celiac Disease: Insights From the CDGEMM Cohort / V. Pucinischi, V. Kenyon, M. Montuori, P. Piemontese, R. Francavilla, L. Norsa, G. Di Nardo, M.E. Baldassarre, M.C. Trovato, M. Perrone, T. Passaro, N. Sansotta, M. Crocco, A. Morelli, F. Malerba, F. Cristofori, L. Elli, A. Fasano, F. Valitutti, M.M. Leonard, M.L. Forchielli, A. Serretiello, C. Vecchi, G.C. De Villsante, G. Venutolo. - In: THE AMERICAN JOURNAL OF GASTROENTEROLOGY. - ISSN 0002-9270. - 121:2(2026 Feb), pp. 554-556. [10.14309/ajg.0000000000003772]

Elevation of tTG-IgA Antibodies in a Prospective Cohort of Children at Risk of Celiac Disease: Insights From the CDGEMM Cohort

L. Norsa;G. Di Nardo;M. Crocco;L. Elli;
2026

Abstract

Celiac disease (CeD) is a common immune-mediated condition that occurs in genetically predisposed individuals. In this study, we examined the trajectory of tissue transglutaminase IgA (tTG-IgA) antibodies in a prospective longitudinal cohort of over 500 children at risk of developing CeD due to having a first-degree relative with CeD. We identified 34 subjects from our cohort and examined tTG-IgA titers at seroconversion and 6 months before tTG-IgA seroconversion. We found that all subjects had normal tTG-IgA 6 months before seroconversion. Thus, we conclude that tTG-IgA elevation in subjects with CeD is a sudden event and its trajectory cannot be used as a marker to predict seroconversion in this population.
anti-transglutaminase antibodies; celiac disease; potential celiac disease;
Settore MEDS-10/A - Gastroenterologia
feb-2026
29-set-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
nihms-2158223.pdf

embargo fino al 01/03/2027

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Licenza: Creative commons
Dimensione 149.62 kB
Formato Adobe PDF
149.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
elevation_of_ttg_iga_antibodies_in_a_prospective.42(1).pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 306.45 kB
Formato Adobe PDF
306.45 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1235778
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact